FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Jahrling

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Anatomy

Vero Cells

Co-author Network

Publications

TOP 3
Haifeng Song; Marisa St Claire; Joseph E Blaney; Russ Byrum; Julie Dyall; Krisztina Janosko; Gerald Jennings; Catherine Jett; Reed F Johnson; Nicole Josleyn; Jing Qin; Peter B Jahrling
Poxvirus antigen staining of immune cells as a biomarker to predict disease outcome in monkeypox and cowpox virus infection in non-human primates.
Jens H Kuhn; Sheli R Radoshitzky; Sina Bavari; Peter B Jahrling
The International Code of Virus Classification and Nomenclature (ICVCN): proposal to delete Rule 3.41.
J A Cann; Lisa E Hensley; Peter B Jahrling; Victoria Wahl-Jensen
Comparative pathology of smallpox and monkeypox in man and macaques.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Jahrling (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Haifeng Song; Marisa St Claire; Joseph E Blaney; Russ Byrum; Julie Dyall; Krisztina Janosko; Gerald Jennings; Catherine Jett; Reed F Johnson; Nicole Josleyn; Jing Qin; Peter B Jahrling
Poxvirus antigen staining of immune cells as a biomarker to predict disease outcome in monkeypox and cowpox virus infection in non-human primates.
PloS one 2013;8(4):e60533.
2013: Jens H Kuhn; Sheli R Radoshitzky; Sina Bavari; Peter B Jahrling
The International Code of Virus Classification and Nomenclature (ICVCN): proposal to delete Rule 3.41.
Archives of virology 2013;158(1):297-9.
2013: J A Cann; Lisa E Hensley; Peter B Jahrling; Victoria Wahl-Jensen
Comparative pathology of smallpox and monkeypox in man and macaques.
Journal of comparative pathology 2013;148(1):6-21.
2012: Amy Papaneri; Matthias J Schnell; Christoph Wirblich; Jennifer A Cann; Kurt Cooper; Peter B Jahrling; Joseph E Blaney
A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence.
Virology 2012;434(1):18-26.
2012: Amy Papaneri; Matthias J Schnell; Christoph Wirblich; Kurt Cooper; Peter B Jahrling; Joseph E Blaney
Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein.
Vaccine 2012;30(43):6136-41.
2012: Danielle V Clark; Peter B Jahrling; James V Lawler
Clinical management of filovirus-infected patients.
Viruses 2012;4(9):1668-86.
2012: Sheli R Radoshitzky; Fabian de Kok-Mercado; Peter B Jahrling; Jens H Kuhn; Sina Bavari
Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses.
Expert opinion on drug discovery 2012;7(7):613-32.
2012: Jason Kindrachuk; Kristen N Kindrachuk; Anthony Kusalik; Scott Napper; Brett Trost; Ryan Arsenault; Peter B Jahrling; Joseph E Blaney
Systems kinomics demonstrates Congo Basin monkeypox virus infection selectively modulates host cell signaling responses as compared to West African monkeypox virus.
Molecular & cellular proteomics : MCP 2012;11(6):M111.015701.
2012: Sharon E Altmann; Lori E Dodd; Julie Dyall; Peter B Jahrling; Reed F Johnson; Jason Paragas; Alvin L Smith; Joseph E Blaney
Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone.
Antiviral research 2012;93(2):305-8.
2012: Jeffrey R Kugelman; Jens H Kuhn; Michael S Lee; Sarah E McCarthy; Sina Bavari; John Michael Dye; Lisa E Hensley; Anna N Honko; Peter B Jahrling; Sheli R Radoshitzky; Cynthia A Rossi; Travis K Warren; Chris A Whitehouse; Gustavo Palacios
Ebola virus genome plasticity as a marker of its passaging history: a comparison of in vitro passaging to non-human primate infection.
PloS one 2012;7(11):e50316.
2012: Sharon E Altmann; Curtis R Brandt; Peter B Jahrling; Joseph E Blaney
Antiviral activity of the EB peptide against zoonotic poxviruses.
Virology journal 2012;9():6.
2011: Reed F Johnson; Jason Paragas; Dan R Ragland; Marisa St Claire; Srikanth Yellayi; John G Bernbaum; Joseph E Blaney; Russ Byrum; Jennifer A Cann; Lori E Dodd; Wenjuan Gu; Catherine Jett; Peter B Jahrling
Simian hemorrhagic fever virus infection of rhesus macaques as a model of viral hemorrhagic fever: clinical characterization and risk factors for severe disease.
Virology 2011;421(2):129-40.
2011: Julie Dyall; Louis Huzella; Peter B Jahrling; Gerald Jennings; Reed F Johnson; Daniel J Mollura; Joseph E Blaney; Russ Byrum; Dar-Yeong Chen; Dan R Ragland; Richard C Reba; Jason Paragas
Evaluation of monkeypox disease progression by molecular imaging.
The Journal of infectious diseases 2011;204(12):1902-11.
2011: Joseph E Blaney; Alexander Freiberg; Michael R Holbrook; Peter B Jahrling; Reed F Johnson; Terry L Juelich; Carey J Myers; Amy Papaneri; Jason Paragas; John G Bernbaum; Christoph Wirblich; Matthias J Schnell
Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses.
Journal of virology 2011;85(20):10605-16.
2011: Reed F Johnson; Jason Paragas; Alvin L Smith; Srikanth Yellayi; Jennifer A Cann; Peter B Jahrling; Anthony Johnson; Joseph E Blaney
Cowpox virus infection of cynomolgus macaques as a model of hemorrhagic smallpox.
Virology 2011;418(2):102-12.
2011: Nancy J Sullivan; Gene Garrard Olinger; SRINIVAS RAO; Keith A Reimann; Mario Roederer; Daphne Stanley; Clement Asiedu; Michael Bailey; Saran Bao; Joan B Geisbert; Thomas W Geisbert; Lisa E Hensley; Anna N Honko; Peter B Jahrling; Joshua Johnson; Richard A Koup; Gary Nabel
CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates.
Nature medicine 2011;17(9):1128-31.
2011: Sheli R Radoshitzky; Cary Retterer; Viktor Volchkov; Victoria Wahl-Jensen; Kelly L Warfield; John N Misasi; M Javad Aman; Sina Bavari; Steven B Bradfute; Xiaoli Chi; James M Cunningham; Lian Dong; Michael Farzan; Jacqueline D Gearhart; Marc A Hogenbirk; Peter B Jahrling; Krishna Kota; Philip J Kranzusch; Jens H Kuhn
Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.
Journal of virology 2011;85(17):8502-13.
2011: Wu Ou; Josie Delisle; Krishnamurthy Konduru; Steven Bradfute; Sheli R Radoshitzky; Cary Retterer; Krishna Kota; Sina Bavari; Jens H Kuhn; Peter B Jahrling; Gerardo Kaplan; Carolyn A Wilson
Development and characterization of rabbit and mouse antibodies against ebolavirus envelope glycoproteins.
Journal of virological methods 2011;174(1-2):99-109.
2011: Mike Bray; James Lawler; Jason Paragas; Peter B Jahrling; Daniel J Mollura
Molecular imaging of influenza and other emerging respiratory viral infections.
The Journal of infectious diseases 2011;203(10):1348-59.
2011: Maryam Keshtkar-Jahromi; Jens H Kuhn; Iva Christova; Steven B Bradfute; Peter B Jahrling; Sina Bavari
Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies.
Antiviral research 2011;90(2):85-92.
2011: Thomas W Geisbert; Michael Bailey; Lisa E Hensley; Clement Asiedu; Joan B Geisbert; Daphne Stanley; Anna Honko; Joshua Johnson; Sabue Mulangu; Maria G Pau; Jerome H H V Custers; Jort Vellinga; Jenny Hendriks; Peter B Jahrling; Mario Roederer; Jaap Goudsmit; Richard A Koup; Nancy J Sullivan
Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge.
Journal of virology 2011;85(9):4222-33.
2011: Reed F Johnson; Julie Dyall; Dan R Ragland; Louis Huzella; Russ Byrum; Catherine Jett; Marisa St Claire; Alvin L Smith; Jason Paragas; Joseph E Blaney; Peter B Jahrling
Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route.
Journal of virology 2011;85(5):2112-25.
2011: Victoria Wahl-Jensen; Jennifer A Cann; Fabian de Kok-Mercado; Robert W Fisher; Lisa E Hensley; John W Huggins; Anthony J Johnson; Thomas Larsen; Jo Lynne Raymond; Kate Rubins; Peter B Jahrling
Progression of pathogenic events in cynomolgus macaques infected with variola virus.
PloS one 2011;6(10):e24832.
2010: Jens H Kuhn; Stephan Becker; Hideki Ebihara; Thomas W Geisbert; Karl M Johnson; Yoshihiro Kawaoka; W Ian Lipkin; Ana I Negredo; Sergey V Netesov; Stuart T Nichol; Gustavo Palacios; Clarence J Peters; Antonio Tenorio; Viktor E Volchkov; Peter B Jahrling
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations.
Archives of virology 2010;155(12):2083-103.
2010: Marc H V van Regenmortel; Donald S. Burke; Charles H Calisher; Ralf G Dietzgen; Claude M Fauquet; Said A Ghabrial; Peter B Jahrling; Karl M Johnson; Michael R Holbrook; Marian C Horzinek; Günther M Keil; Jens H Kuhn; Brian W J Mahy; Giovanni P Martelli; Craig Pringle; Edward Rybicki; Tim Skern; Robert B Tesh; Victoria Wahl-Jensen; Peter J Walker; Scott C Weaver
A proposal to change existing virus species names to non-Latinized binomials.
Archives of virology 2010;155(11):1909-19.
2010: Thomas W Geisbert; Michael Bailey; Joan B Geisbert; Clement Asiedu; Mario Roederer; Maria Grazia-Pau; Jerome H H V Custers; Peter B Jahrling; Jaap Goudsmit; Richard A Koup; Nancy J Sullivan
Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates.
Journal of virology 2010;84(19):10386-94.
2010: Lisa E Hensley; Sabue Mulangu; Clement Asiedu; Joshua Johnson; Anna N Honko; Daphne Stanley; Giulia Fabozzi; Stuart T Nichol; Thomas G Ksiazek; Pierre E Rollin; Victoria Wahl-Jensen; Michael Bailey; Peter B Jahrling; Mario Roederer; Richard A Koup; Nancy J Sullivan
Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species.
PLoS pathogens 2010;6(5):e1000904.
2010: Jens H Kuhn; Peter B Jahrling
Clarification and guidance on the proper usage of virus and virus species names.
Archives of virology 2010;155(4):445-53.
2009: James LeDuc; Kevin Anderson; Marshall E Bloom; Ricardo Carrion; Heinz Feldmann; J Patrick Fitch; Joan B Geisbert; Thomas W Geisbert; Michael R Holbrook; Peter B Jahrling; Thomas G Ksiazek
Potential impact of a 2-person security rule on BioSafety Level 4 laboratory workers.
Emerging infectious diseases 2009;15(7):e1.
2009: Abdulnaser Alkhalil; Sarah Strand; Eric Mucker; John W Huggins; Peter B Jahrling; Sofi M Ibrahim
Inhibition of monkeypox virus replication by RNA interference.
Virology journal 2009;6():188.
2008: Thomas W Geisbert; Kathleen M Daddario-DiCaprio; Mark G Lewis; Joan B Geisbert; Allen Grolla; Anders Leung; Jason Paragas; Lennox Matthias; Mark A Smith; Steven M Jones; Lisa E Hensley; Heinz Feldmann; Peter B Jahrling
Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates.
PLoS pathogens 2008;4(11):e1000225.
2008: James W Le Duc; Kevin Anderson; Marshall E Bloom; James E Estep; Heinz Feldmann; Joan B Geisbert; Thomas W Geisbert; Lisa Hensley; Michael Holbrook; Peter B Jahrling; Thomas G Ksiazek; George W Korch; Jean L Patterson; John P Skvorak; Hana Weingartl
Framework for leadership and training of Biosafety Level 4 laboratory workers.
Emerging infectious diseases 2008;14(11):1685-8.
2007: Peter B Jahrling; Joan B Geisbert; James R Swearengen; Thomas Larsen; Thomas W Geisbert
Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates.
The Journal of infectious diseases 2007;196 Suppl 2():S400-3.
2007: Lisa E Hensley; Edward L Stevens; S Betty Yan; Joan B Geisbert; William L Macias; Tom Larsen; Kathleen M Daddario-DiCaprio; Gail H Cassell; Peter B Jahrling; Thomas W Geisbert
Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever.
The Journal of infectious diseases 2007;196 Suppl 2():S390-9.
2007: Thomas Larsen; Edward L Stevens; Kelly J Davis; Joan B Geisbert; Kathleen M Daddario-DiCaprio; Peter B Jahrling; Lisa E Hensley; Thomas W Geisbert
Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus.
The Journal of infectious diseases 2007;196 Suppl 2():S323-8.
2007: James Norman Mills; Herminia Alva; Barbara A Ellis; Kent D Wagoner; James E Childs; Gladys Calderón; Delia A Enría; Peter B Jahrling
Dynamics of oliveros virus infection in rodents in central Argentina.
Vector borne and zoonotic diseases (Larchmont, N.Y.) 2007;7(3):315-23.
2007: Kate Rubins; Lisa E Hensley; Victoria Wahl-Jensen; Kathleen M Daddario-DiCaprio; Howard A Young; Douglas S Reed; Peter B Jahrling; Patrick O Brown; David A Relman; Thomas W Geisbert
The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever.
Genome biology 2007;8(8):R174.
2007: Gustavo Palacios; Phenix-Lan Quan; Omar Jabado; Sean Conlan; David L Hirschberg; Yang Liu; Junhui Zhai; Neil Renwick; Jeffrey Hui; Hedi Hegyi; Allen Grolla; James E Strong; Jonathan S Towner; Thomas W Geisbert; Peter B Jahrling; Cornelia Büchen-Osmond; Heinz Ellerbrok; Maria Paz Sanchez-Seco; Yves lussier; Pierre Formenty; M Stuart T Nichol; Heinz Feldmann; Thomas Briese; W Ian Lipkin
Panmicrobial oligonucleotide array for diagnosis of infectious diseases.
Emerging infectious diseases 2007;13(1):73-81.
2007: Wendelien B Oswald; Thomas W Geisbert; Kelly J Davis; Joan B Geisbert; Nancy J Sullivan; Peter B Jahrling; Paul W H I Parren; Dennis R Burton
Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys.
PLoS pathogens 2007;3(1):e9.
2006: Thomas W Geisbert; Lisa E Hensley; Elliott Kagan; Erik Zhaoying Yu; Joan B Geisbert; Kathleen M Daddario-DiCaprio; Elizabeth A Fritz; Peter B Jahrling; Kevin McClintock; Janet R Phelps; Amy C H Lee; Adam Judge; Lloyd B Jeffs; Ian MacLachlan
Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference.
The Journal of infectious diseases 2006;193(12):1650-7.
2006: Aileen M Marty; Peter B Jahrling; Thomas W Geisbert
Viral hemorrhagic fevers.
Clinics in laboratory medicine 2006;26(2):345-86, viii.
2006: Nancy J Sullivan; Thomas W Geisbert; Joan B Geisbert; Devon Shedlock; Ling Xu; Laurie Lamoreaux; Jerome H H V Custers; Paul M Popernack; Zhi-Yong Yang; Maria G Pau; Mario Roederer; Richard A Koup; Jaap Goudsmit; Peter B Jahrling; Gary Nabel
Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs.
PLoS medicine 2006;3(6):e177.
2006: James V Lawler; Timothy Endy; Lisa E Hensley; Aura Garrison; Elizabeth A Fritz; May Lesar; Ralph S Baric; David A Kulesh; David Norwood; Leonard P Wasieloski; Melanie P Ulrich; Tom R Slezak; Elizabeth Vitalis; John W Huggins; Peter B Jahrling; Jason Paragas
Cynomolgus macaque as an animal model for severe acute respiratory syndrome.
PLoS medicine 2006;3(5):e149.
2006: Kathleen M Daddario-DiCaprio; Thomas W Geisbert; Ute Ströher; Joan B Geisbert; Allen Grolla; Elizabeth A Fritz; Lisa Fernando; Elliott Kagan; Peter B Jahrling; Lisa E Hensley; Steven M Jones; Heinz Feldmann
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment.
Lancet 2006;367(9520):1399-404.
2006: Gustavo Palacios; Thomas Briese; Vishal Kapoor; Omar Jabado; Zhiqiang Liu; Marietjie Venter; Junhui Zhai; Neil Renwick; Allen Grolla; Thomas W Geisbert; Christian Drosten; Jonathan S Towner; Jingyue Ju; Janusz T Paweska; Stuart T Nichol; Robert Swanepoel; Heinz Feldmann; Peter B Jahrling; W Ian Lipkin
MassTag polymerase chain reaction for differential diagnosis of viral hemorrhagic fever.
Emerging infectious diseases 2006;12(4):692-5.
2005: Peter B Jahrling; Elizabeth A Fritz; Lisa E Hensley
Countermeasures to the bioterrorist threat of smallpox.
Current molecular medicine 2005;5(8):817-26.
2005: Lisa E Hensley; Steven M Jones; Heinz Feldmann; Peter B Jahrling; Thomas W Geisbert
Ebola and Marburg viruses: pathogenesis and development of countermeasures.
Current molecular medicine 2005;5(8):761-72.
2005: Chris Druar; Surinder S Saini; Meredith A Cossitt; Fei Yu; Xiangguo Qiu; Thomas W Geisbert; Steven Jones; Peter B Jahrling; Donald I H Stewart; Erik J Wiersma
Analysis of the expressed heavy chain variable-region genes of Macaca fascicularis and isolation of monoclonal antibodies specific for the Ebola virus' soluble glycoprotein.
Immunogenetics 2005;57(10):730-8.
2005: Nanhai Chen; Guiyun Li; M Kathryn Liszewski; John P Atkinson; Peter B Jahrling; Zehua Feng; Jill Schriewer; Charles Buck; Chunlin Wang; Elliot J Lefkowitz; Joseph J Esposito; Tiara Harms; Inger K Damon; Rachel L Roper; Chris Upton; R Mark L Buller
Virulence differences between monkeypox virus isolates from West Africa and the Congo basin.
Virology 2005;340(1):46-63.
2005: Steven M Jones; Heinz Feldmann; Ute Ströher; Joan B Geisbert; Lisa Fernando; Allen Grolla; Hans-Dieter Klenk; Nancy J Sullivan; Viktor Volchkov; Elizabeth A Fritz; Kathleen M Daddario; Lisa E Hensley; Peter B Jahrling; Thomas W Geisbert
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.
Nature medicine 2005;11(7):786-90.
2005: Thomas W Geisbert; Steven Jones; Elizabeth A Fritz; Amy C Shurtleff; Joan B Geisbert; Ryan Liebscher; Allen Grolla; Ute Ströher; Lisa Fernando; Kathleen M Daddario; Mary C Guttieri; Bianca R Mothé; Tom Larsen; Lisa E Hensley; Peter B Jahrling; Heinz Feldmann
Development of a new vaccine for the prevention of Lassa fever.
PLoS medicine 2005;2(6):e183.
2004: Thomas W Geisbert; Peter B Jahrling
Exotic emerging viral diseases: progress and challenges.
Nature medicine 2004;10(12 Suppl):S110-21.
2004: Jorge E Pinzon; James M Wilson; Compton J Tucker; Ray Arthur; Peter B Jahrling; Pierre Formenty
Trigger events: enviroclimatic coupling of Ebola hemorrhagic fever outbreaks.
The American journal of tropical medicine and hygiene 2004;71(5):664-74.
2004: Kate Rubins; Lisa E Hensley; Peter B Jahrling; Adeline R Whitney; Thomas W Geisbert; John W Huggins; Art Owen; James LeDuc; Patrick O Brown; David A Relman
The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(42):15190-5.
2004: Peter B Jahrling; Lisa E Hensley; Mark J Martinez; James LeDuc; Kate Rubins; David A Relman; John W Huggins
Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(42):15196-200.
2004: Jay W Hooper; E Thompson; C Wilhelmsen; M Zimmerman; M Ait Ichou; S E Steffen; Connie S Schmaljohn; Alan L Schmaljohn; Peter B Jahrling
Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.
Journal of virology 2004;78(9):4433-43.
2004: Patricia L Earl; Jeffrey L Americo; Linda S Wyatt; Leigh Anne Eller; J Charles Whitbeck; Gary H Cohen; Roselyn J Eisenberg; Christopher J Hartmann; David L Jackson; David A Kulesh; Mark J Martinez; David M Miller; Eric Mucker; Joshua D Shamblin; Susan H Zwiers; John W Huggins; Peter B Jahrling; Bernard Moss
Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.
Nature 2004;428(6979):182-5.
2004: Lisa E Hensley; Lisa E Fritz; Peter B Jahrling; Christopher L Karp; John W Huggins; Thomas W Geisbert
Interferon-beta 1a and SARS coronavirus replication.
Emerging infectious diseases 2004;10(2):317-9.
2004: David A Kulesh; Robert O Baker; Bonnie M Loveless; David Norwood; Susan H Zwiers; Eric Mucker; Chris Hartmann; Rafael Herrera; David Miller; Deanna Christensen; Leonard P Wasieloski; John W Huggins; Peter B Jahrling
Smallpox and pan-orthopox virus detection by real-time 3'-minor groove binder TaqMan assays on the roche LightCycler and the Cepheid smart Cycler platforms.
Journal of clinical microbiology 2004;42(2):601-9.
2004: Douglas S Reed; Lisa E Hensley; Joan B Geisbert; Peter B Jahrling; Thomas W Geisbert
Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques.
Viral immunology 2004;17(3):390-400.
2004: Randal J Schoepp; Michelle D Morin; Mark J Martinez; David A Kulesh; Lisa E Hensley; Thomas W Geisbert; Daniel R Brady; Peter B Jahrling
Detection and identification of Variola virus in fixed human tissue after prolonged archival storage.
Laboratory investigation; a journal of technical methods and pathology 2004;84(1):41-8.
2003: Thomas W Geisbert; Lisa E Hensley; Peter B Jahrling; Tom Larsen; Joan B Geisbert; Jason Paragas; Howard A Young; Terry M Fredeking; William E Rote; George P Vlasuk
Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.
Lancet 2003;362(9400):1953-8.
2003: Thomas W Geisbert; Peter B Jahrling
Towards a vaccine against Ebola virus.
Expert review of vaccines 2003;2(6):777-89.
2003: Thomas W Geisbert; Howard A Young; Peter B Jahrling; Kelly J Davis; Elliott Kagan; Lisa E Hensley
Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event.
The Journal of infectious diseases 2003;188(11):1618-29.
2003: Thomas W Geisbert; Howard A Young; Peter B Jahrling; Kelly J Davis; Tom Larsen; Elliott Kagan; Lisa E Hensley
Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells.
The American journal of pathology 2003;163(6):2371-82.
2003: Thomas W Geisbert; Lisa E Hensley; Tom Larsen; Howard A Young; Douglas S Reed; Joan B Geisbert; Dana P Scott; Elliott Kagan; Peter B Jahrling; Kelly J Davis
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.
The American journal of pathology 2003;163(6):2347-70.
2003: Boyd Yount; Kris Curtis; Elizabeth A Fritz; Lisa E Hensley; Peter B Jahrling; Erik Prentice; Mark Denison; Thomas W Geisbert; Ralph S Baric
Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(22):12995-3000.
2003: Jenny Riemenschneider; Aura Garrison; Joan B Geisbert; Peter B Jahrling; Michael Hevey; diane negley; Alan L Schmaljohn; John Lee; Mary Kate Hart; Lorna VanderZanden; David M Custer; Mike Bray; Albert Ruff; Bruce Ivins; Anthony Bassett; Cynthia Rossi; Connie S Schmaljohn
Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus.
Vaccine 2003;21(25-26):4071-80.
2003: Nancy J Sullivan; Thomas W Geisbert; Joan B Geisbert; Ling Xu; Zhi-Yong Yang; Mario Roederer; Richard A Koup; Peter B Jahrling; Gary Nabel
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.
Nature 2003;424(6949):681-4.
2003: M Sofi Ibrahim; David A Kulesh; Sharron S Saleh; Inger K Damon; Joseph J Esposito; Alan L Schmaljohn; Peter B Jahrling
Real-time PCR assay to detect smallpox virus.
Journal of clinical microbiology 2003;41(8):3835-9.
2003: Jenny L Mellquist-Riemenschneider; Aura Garrison; Joan B Geisbert; Kamal U Saikh; Kelli D Heidebrink; Peter B Jahrling; Robert G Ulrich; Connie S Schmaljohn
Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs.
Virus research 2003;92(2):187-93.
2003: Peter B Jahrling
Commentary on Dr. Alan zelicoff's Analysis of the Aralsk outbreak (No. 4).
Critical reviews in microbiology 2003;29(2):171-2; discussion 183-90.
2002: Felix Meissner; Toshiaki Maruyama; Marco Frentsch; Ann J Hessell; Luis L Rodriguez; Thomas W Geisbert; Peter B Jahrling; Dennis R Burton; Paul W H I Parren
Detection of antibodies against the four subtypes of ebola virus in sera from any species using a novel antibody-phage indicator assay.
Virology 2002;300(2):236-43.
2002: Mangala Rao; Mike Bray; Carl R Alving; Peter B Jahrling; Gary R Matyas
Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.
Journal of virology 2002;76(18):9176-85.
2002: James LeDuc; Inger K Damon; David A Relman; John W Huggins; Peter B Jahrling
Smallpox research activities: U.S. interagency collaboration, 2001.
Emerging infectious diseases 2002;8(7):743-5.
2002: Sergei N Shchelkunov; Alexei Totmenin; PF Safronov; MV Mikheev; Valery Gutorov; OI Ryazankina; NA Petrov; Igor V Babkin; EA Uvarova; LS Sandakhchiev; JR Sisler; Joseph J Esposito; Inger K Damon; Peter B Jahrling; Bernard Moss
Analysis of the monkeypox virus genome.
Virology 2002;297(2):172-94.
2002: Paul W H I Parren; Thomas W Geisbert; Toshiaki Maruyama; Peter B Jahrling; Dennis R Burton
Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody.
Journal of virology 2002;76(12):6408-12.
2002: Igor S Lukashevich; Mahmoud Djavani; Juan D Rodas; Juan Carlos Zapata; Amy L Usborne; Carol Emerson; Jacque Mitchen; Peter B Jahrling; Maria Salvato
Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus.
Journal of medical virology 2002;67(2):171-86.
2002: Luciana Borio; Thomas V Inglesby; Clarence Peters; Alan L Schmaljohn; James Hughes; Peter B Jahrling; Thomas Ksiazek; Karl M Johnson; Andrea Nikki Meyerhoff; Tara O'Toole; Michael S Ascher; John G Bartlett; Joel G Breman; Edward M Eitzen; Margaret Hamburg; Jerry Hauer; Donald A Henderson; Richard T Johnson; Gigi Kwik; Marcelle Layton; Scott R Lillibridge; Gary Nabel; Michael Osterholm; Trish M Perl; Philip Russell; Kevin Tonat
Hemorrhagic fever viruses as biological weapons: medical and public health management.
JAMA : the journal of the American Medical Association 2002;287(18):2391-405.
2002: Sergei N Shchelkunov; Alexei Totmenin; PF Safronov; Valery Gutorov; OI Ryazankina; NA Petrov; Igor V Babkin; EA Uvarova; MV Mikheev; JR Sisler; Joseph J Esposito; Peter B Jahrling; Bernard Moss; LS Sandakhchiev
Multiple genetic differences between the monkeypox and variola viruses.
Doklady. Biochemistry and biophysics 2002;384():143-7.
2002: Thomas W Geisbert; Peter Pushko; Kevin Anderson; Jonathan Smith; Kelly J Davis; Peter B Jahrling
Evaluation in nonhuman primates of vaccines against Ebola virus.
Emerging infectious diseases 2002;8(5):503-7.
2002: Lisa E Hensley; Howard A Young; Peter B Jahrling; Thomas W Geisbert
Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily.
Immunology letters 2002;80(3):169-79.
2002: Thomas W Geisbert; Lisa E Hensley; Joan B Geisbert; Peter B Jahrling
Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections.
Virology 2002;293(1):15-9.
2001: G M Zaucha; Peter B Jahrling; Thomas W Geisbert; James R Swearengen; Lisa E Hensley
The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis).
Laboratory investigation; a journal of technical methods and pathology 2001;81(12):1581-600.
2001: P Pushko; Joan B Geisbert; M Parker; Peter B Jahrling; J Smith
Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.
Journal of virology 2001;75(23):11677-85.
2001: Sergei N Shchelkunov; Alexei Totmenin; Igor V Babkin; PF Safronov; OI Ryazankina; NA Petrov; Valery Gutorov; EA Uvarova; MV Mikheev; JR Sisler; Joseph J Esposito; Peter B Jahrling; Bernard Moss; LS Sandakhchiev
Human monkeypox and smallpox viruses: genomic comparison.
FEBS letters 2001;509(1):66-70.
2001: Michael Hevey; diane negley; Lorna VanderZanden; RF Tammariello; Joan B Geisbert; Connie S Schmaljohn; Jonathan F Smith; Peter B Jahrling; Alan L Schmaljohn
Marburg virus vaccines: comparing classical and new approaches.
Vaccine 2001;20(3-4):586-93.
2001: David R Franz; Peter B Jahrling; D J McClain; D L Hoover; W Russell Byrne; Julie A Pavlin; George W Christopher; Theodore J Cieslak; Arthur M Friedlander; Edward M Eitzen
Clinical recognition and management of patients exposed to biological warfare agents.
Clinics in laboratory medicine 2001;21(3):435-73.
2001: James LeDuc; Peter B Jahrling
Strengthening national preparedness for smallpox: an update.
Emerging infectious diseases 2001;7(1):155-7.
2000: Peter Pushko; Mike Bray; George V Ludwig; M Parker; Alan L Schmaljohn; A Sanchez; Peter B Jahrling; Jonathan F Smith
Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.
Vaccine 2000;19(1):142-53.
2000: Thomas W Geisbert; Lisa E Hensley; T R Gibb; KE Steele; NK Jaax; Peter B Jahrling
Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses.
Laboratory investigation; a journal of technical methods and pathology 2000;80(2):171-86.
1999: Mangala Rao; Gary R Matyas; F Grieder; K Anderson; Peter B Jahrling; Carl R Alving
Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid A.
Vaccine 1999;17(23-24):2991-8.
1999: Toshiaki Maruyama; Luis L Rodriguez; Peter B Jahrling; A Sanchez; A S Khan; S T Nichol; Clarence Peters; Paul W H I Parren; Dennis R Burton
Ebola virus can be effectively neutralized by antibody produced in natural human infection.
Journal of virology 1999;73(7):6024-30.
1999: Donald A Henderson; Thomas V Inglesby; John G Bartlett; Michael S Ascher; Edward M Eitzen; Peter B Jahrling; Jerry Hauer; Marcelle Layton; Joseph McDade; Michael Osterholm; Tara O'Toole; Gerald Parker; Trish M Perl; Philip K Russell; Kevin Tonat
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
JAMA : the journal of the American Medical Association 1999;281(22):2127-37.
1999: Peter B Jahrling; Thomas W Geisbert; Joan B Geisbert; James R Swearengen; Mike Bray; NK Jaax; John W Huggins; James LeDuc; Clarence Peters
Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections.
The Journal of infectious diseases 1999;179 Suppl 1():S224-34.
1999: B M Connolly; KE Steele; Kelly J Davis; Thomas W Geisbert; WM Kell; NK Jaax; Peter B Jahrling
Pathogenesis of experimental Ebola virus infection in guinea pigs.
The Journal of infectious diseases 1999;179 Suppl 1():S203-17.
1999: Thomas G Ksiazek; C P West; P E Rollin; Peter B Jahrling; Clarence Peters
ELISA for the detection of antibodies to Ebola viruses.
The Journal of infectious diseases 1999;179 Suppl 1():S192-8.
1999: P Reiter; M Turell; R Coleman; B Miller; G Maupin; J Liz; A Kuehne; J Barth; Joan B Geisbert; David J Dohm; J Glick; J Pecor; R Robbins; Peter B Jahrling; C Peters; T Ksiazek
Field investigations of an outbreak of Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: arthropod studies.
The Journal of infectious diseases 1999;179 Suppl 1():S148-54.
1999: Pierre E Rollin; R J Williams; DS Bressler; S Pearson; M Cottingham; G Pucak; Anthony Sanchez; SG Trappier; R L Peters; Patricia W Greer; Sherif Zaki; T Demarcus; Kate Hendricks; M Kelley; D Simpson; T W Geisbert; Peter B Jahrling; Clarence Peters; Thomas G Ksiazek
Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States.
The Journal of infectious diseases 1999;179 Suppl 1():S108-14.
1998: Lorna VanderZanden; Mike Bray; D Fuller; T Roberts; David M Custer; Kristin Spik; Peter B Jahrling; John W Huggins; Alan L Schmaljohn; Connie S Schmaljohn
DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge.
Virology 1998;246(1):134-44.
1998: MS Ibrahim; RS Lofts; Peter B Jahrling; Erik A Henchal; V W Weedn; MA Northrup; P Belgrader
Real-time microchip PCR for detecting single-base differences in viral and human DNA.
Analytical chemistry 1998;70(9):2013-7.
1997: Michael Hevey; diane negley; Joan B Geisbert; Peter B Jahrling; Alan L Schmaljohn
Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants.
Virology 1997;239(1):206-16.
1997: David R Franz; Peter B Jahrling; Arthur M Friedlander; D J McClain; D L Hoover; W R Bryne; Julie A Pavlin; George W Christopher; Edward M Eitzen
Clinical recognition and management of patients exposed to biological warfare agents.
JAMA : the journal of the American Medical Association 1997;278(5):399-411.
1997: Kelly J Davis; Arthur O. Anderson; Thomas W Geisbert; KE Steele; Joan B Geisbert; Peter Vogel; B M Connolly; John W Huggins; Peter B Jahrling; NK Jaax
Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells.
Archives of pathology & laboratory medicine 1997;121(8):805-19.
1997: MS Ibrahim; Joseph J Esposito; Peter B Jahrling; RS Lofts
The potential of 5' nuclease PCR for detecting a single-base polymorphism in Orthopoxvirus.
Molecular and cellular probes 1997;11(2):143-7.
1996: William Hall; Thomas W Geisbert; John W Huggins; Peter B Jahrling
Experimental infection of guinea pigs with Venezuelan hemorrhagic fever virus (Guanarito): a model of human disease.
The American journal of tropical medicine and hygiene 1996;55(1):81-8.
1996: James Norman Mills; Julio G Barrera Oro; DS Bressler; J E Childs; Robert B Tesh; J F Smith; Delia Enria; Thomas W Geisbert; K T McKee; Michael D Bowen; Clarence Peters; Peter B Jahrling
Characterization of Oliveros virus, a new member of the Tacaribe complex (Arenaviridae: Arenavirus).
The American journal of tropical medicine and hygiene 1996;54(4):399-404.
1996: NK Jaax; Kelly J Davis; T J Geisbert; Peter Vogel; G P Jaax; M Topper; Peter B Jahrling
Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure.
Archives of pathology & laboratory medicine 1996;120(2):140-55.
1996: Clarence Peters; Peter B Jahrling; Ali S Khan
Patients infected with high-hazard viruses: scientific basis for infection control.
Archives of virology. Supplementum 1996;11():141-68.
1996: Peter B Jahrling; Joan B Geisbert; J R Swearengen; G P Jaax; T Lewis; John W Huggins; J J Schmidt; James LeDuc; Clarence Peters
Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses.
Archives of virology. Supplementum 1996;11():135-40.
1996: Peter B Jahrling; Thomas W Geisbert; NK Jaax; M A Hanes; Thomas G Ksiazek; Clarence Peters
Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 U.S. epizootic.
Archives of virology. Supplementum 1996;11():115-34.
1996: E D Johnson; B K Johnson; D Silverstein; Peter M Tukei; Thomas W Geisbert; Anthony Sanchez; Peter B Jahrling
Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya.
Archives of virology. Supplementum 1996;11():101-14.
1995: NK Jaax; Peter B Jahrling; Thomas W Geisbert; Joan B Geisbert; KE Steele; K McKee; D Nagley; E Johnson; G Jaax; C Peters
Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory.
Lancet 1995;346(8991-8992):1669-71.
1995: Thomas W Geisbert; Peter B Jahrling
Differentiation of filoviruses by electron microscopy.
Virus research 1995;39(2-3):129-50.
1995: E Johnson; NK Jaax; J White; Peter B Jahrling
Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus.
International journal of experimental pathology 1995;76(4):227-36.
1994: R H Kenyon; B Niklasson; Peter B Jahrling; Thomas W Geisbert; L Svensson; Aril Frydén; M Bengtsson; U Foberg; C J Peters
Virologic investigation of a case of suspected haemorrhagic fever.
Research in virology 1994;145(6):397-406.
1993: Deborah L Birx; Mark G Lewis; Maryanne Vahey; K Tencer; P M Zack; C R Brown; Peter B Jahrling; G Tosato; Donald S. Burke; Robert R Redfield
Association of interleukin-6 in the pathogenesis of acutely fatal SIVsmm/PBj-14 in pigtailed macaques.
AIDS research and human retroviruses 1993;9(11):1123-9.
1993: Thomas W Geisbert; Peter B Jahrling; J W Ezzell
Use of immunoelectron microscopy to demonstrate Francisella tularensis.
Journal of clinical microbiology 1993;31(7):1936-9.
1993: Avigdor Shafferman; Mark G Lewis; Francine E McCutchan; Raoul E Benveniste; Peter B Jahrling; Donald S. Burke; G A Eddy
Prevention of transmission of simian immunodeficiency virus from vaccinated macaques that developed transient virus infection following challenge.
Vaccine 1993;11(8):848-52.
1992: Mark G Lewis; P M Zack; W R Elkins; Peter B Jahrling
Infection of rhesus and cynomolgus macaques with a rapidly fatal SIV (SIVSMM/PBj) isolate from sooty mangabeys.
AIDS research and human retroviruses 1992;8(9):1631-9.
1992: Avigdor Shafferman; Mark G Lewis; Francine E McCutchan; Raoul E Benveniste; Peter B Jahrling; R L Hickman; C Y Lai; Donald S. Burke; G A Eddy
Vaccination of macaques with SIV conserved envelope peptides suppressed infection and prevented disease progression and transmission.
AIDS research and human retroviruses 1992;8(8):1483-7.
1992: Thomas G Ksiazek; P E Rollin; Peter B Jahrling; E Johnson; D W Dalgard; C J Peters
Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates.
Journal of clinical microbiology 1992;30(4):947-50.
1992: D W Dalgard; R J Hardy; S L Pearson; G J Pucak; R V Quander; P M Zack; C J Peters; Peter B Jahrling
Combined simian hemorrhagic fever and Ebola virus infection in cynomolgus monkeys.
Laboratory animal science 1992;42(2):152-7.
1992: Thomas W Geisbert; Peter B Jahrling; M A Hanes; P M Zack
Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States.
Journal of comparative pathology 1992;106(2):137-52.
1992: C J Peters; Peter B Jahrling; Thomas G Ksiazek; E D Johnson; H W Lupton
Filovirus contamination of cell cultures.
Developments in biological standardization 1992;76():267-74.
1991: Avigdor Shafferman; Peter B Jahrling; Raoul E Benveniste; Mark G Lewis; T J Phipps; F Eden-McCutchan; J Sadoff; G A Eddy; Donald S. Burke
Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(16):7126-30.
1991: Thomas W Geisbert; J B Rhoderick; Peter B Jahrling
Rapid identification of Ebola virus and related filoviruses in fluid specimens using indirect immunoelectron microscopy.
Journal of clinical pathology 1991;44(6):521-2.
1991: U Foberg; Aril Frydén; B Isaksson; Peter B Jahrling; A Johnson; K McKee; B Niklasson; B Normann; C Peters; M Bengtsson
Viral haemorrhagic fever in Sweden: experiences from management of a case.
Scandinavian journal of infectious diseases 1991;23(2):143-51.
1990: Thomas W Geisbert; Peter B Jahrling
Use of immunoelectron microscopy to show Ebola virus during the 1989 United States epizootic.
Journal of clinical pathology 1990;43(10):813-6.
1990: R H Kenyon; R M Condie; Peter B Jahrling; C J Peters
Protection of guinea pigs against experimental Argentine hemorrhagic fever by purified human IgG: importance of elimination of infected cells.
Microbial pathogenesis 1990;9(4):219-26.
1990: Peter B Jahrling; Thomas W Geisbert; D W Dalgard; E D Johnson; Thomas G Ksiazek; William Hall; C J Peters
Preliminary report: isolation of Ebola virus from monkeys imported to USA.
Lancet 1990;335(8688):502-5.
1989: C J Peters; C T Liu; G W Anderson; J C Morrill; Peter B Jahrling
Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted.
Reviews of infectious diseases 1989;11 Suppl 4():S743-9.
1989: R M Lewis; J C Morrill; Peter B Jahrling; T M Cosgriff
Replication of hemorrhagic fever viruses in monocytic cells.
Reviews of infectious diseases 1989;11 Suppl 4():S736-42.
1988: R M Lewis; T M Cosgriff; B Y Griffin; J Rhoderick; Peter B Jahrling
Immune serum increases arenavirus replication in monocytes.
The Journal of general virology 1988;69 ( Pt 7)():1735-9.
1987: M H Monson; A K Cole; J D Frame; Janet R Serwint; S Alexander; Peter B Jahrling
Pediatric Lassa fever: a review of 33 Liberian cases.
The American journal of tropical medicine and hygiene 1987;36(2):408-15.
1987: T M Cosgriff; Peter B Jahrling; J P Chen; L A Hodgson; R M Lewis; D E Green; J I Smith
Studies of the coagulation system in arenaviral hemorrhagic fever: experimental infection of strain 13 guinea pigs with Pichinde virus.
The American journal of tropical medicine and hygiene 1987;36(2):416-23.
1987: C J Peters; Peter B Jahrling; C T Liu; R H Kenyon; K T McKee; Julio G Barrera Oro
Experimental studies of arenaviral hemorrhagic fevers.
Current topics in microbiology and immunology 1987;134():5-68.
1985: Peter B Jahrling; J D Frame; J B Rhoderick; M H Monson
Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization.
Transactions of the Royal Society of Tropical Medicine and Hygiene 1985;79(3):380-4.
1985: Peter B Jahrling; J D Frame; S B Smith; M H Monson
Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates.
Transactions of the Royal Society of Tropical Medicine and Hygiene 1985;79(3):374-9.
1984: Peter B Jahrling; C J Peters; E L Stephen
Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys.
The Journal of infectious diseases 1984;149(3):420-7.
1984: Arthur M Friedlander; Peter B Jahrling; P Merrill; S Tobery
Inhibition of mouse peritoneal macrophage DNA synthesis by infection with the arenavirus Pichinde.
Infection and immunity 1984;43(1):283-8.
1984: M H Monson; J D Frame; Peter B Jahrling; K Alexander
Endemic Lassa fever in Liberia. I. Clinical and epidemiological aspects at Curran Lutheran Hospital, Zorzor, Liberia.
Transactions of the Royal Society of Tropical Medicine and Hygiene 1984;78(4):549-53.
1984: J D Frame; Peter B Jahrling; J E Yalley-Ogunro; M H Monson
Endemic Lassa fever in Liberia. II. Serological and virological findings in hospital patients.
Transactions of the Royal Society of Tropical Medicine and Hygiene 1984;78(5):656-60.
1983: J W Huggins; Peter B Jahrling; W Rill; C D Linden
Characterization of the binding of the TC-83 strain of Venezuelan Equine encephalomyelitis virus to BW-J-M, a mouse macrophage-like cell line.
The Journal of general virology 1983;64 (Pt 1)():149-57.
1983: Peter B Jahrling; R A Hesse; Arthur O. Anderson; J D Gangemi
Opsonization of alphaviruses in hamsters.
Journal of medical virology 1983;12(1):1-16.
1982: R T Callis; Peter B Jahrling; A DePaoli
Pathology of Lassa virus infection in the rhesus monkey.
The American journal of tropical medicine and hygiene 1982;31(5):1038-45.
1982: Peter B Jahrling; S Smith; R A Hesse; J B Rhoderick
Pathogenesis of Lassa virus infection in guinea pigs.
Infection and immunity 1982;37(2):771-8.
1981: Peter B Jahrling; R A Hesse; J B Rhoderick; M A Elwell; J B Moe
Pathogenesis of a pichinde virus strain adapted to produce lethal infections in guinea pigs.
Infection and immunity 1981;32(2):872-80.
1980: Peter B Jahrling; R A Hesse; G A Eddy; K M Johnson; R T Callis; E L Stephen
Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin.
The Journal of infectious diseases 1980;141(5):580-9.